News

Ipsen Receives Complete Response Letter from U.S. FDA

Read more Share

Tell the FDA What It's Like to Live With FOP

Read more Share

Regeneron OPTIMA Phase III Trial Now Recruiting

Read more Share

You Make Our Family Services Programs Possible

Read more Share

IFOPA-funded Gene Therapy Research Published in Nature Communications

Read more Share

Announcement from BioCryst Pharmaceuticals About BCX9250

Read more Share

IPSEN Publishes Burden of Illness Study and Releases Plain Language Summary

Read more Share

FDA Advisory Committee Meeting for Palovarotene Capsules Postponed

Read more Share

Updated Glossary Makes FOP Answers Easier to Find

Read more Share

The WILL Project Continues to Innovate with FOP Community

Read more Share

Make a Difference

Donate Connect Fundraise
Already a Member? Sign In

Sign Up for FOP Connection, Our Monthly eNewsletter

X